160 Health International (HKSE:02656) Other Financing: HK$369.5 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02656 160 Health International Ltd HKSE:02656
8 GF Score
Price HK$9.64
! 5 Warning Signs
View Full Analysis

What is 160 Health International Other Financing?

160 Health International HKSE:02656 -2.87% 8 Other Financing is HK$369.5 Mil as of Dec. 2025. GuruFocus rates HKSE:02656 with a GF Score™ of 8/100. The stock has 5 warning signs investors should review.

160 Health International's Other Financing for the six months ended in Dec. 2025 was HK$372.6 Mil.

160 Health International's Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was HK$369.5 Mil.

160 Health International Other Financing Historical Data

* Premium members only.

The historical data trend for 160 Health International's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

160 Health International Other Financing Chart

160 Health International Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Other Financing
-10.52 -5.07 -2.93 -33.93

160 Health International Semi-Annual Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
Other Financing Get a 7-Day Free Trial 0.00 -2.29 -0.66 -3.11 372.61
HKSE:02656
8GF Score
160 Health International Ltd HKSE:02656
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

160 Health International Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$369.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of HK$369.5 Mil mean?
160 Health International (HKSE:02656) has a Other Financing of HK$369.5 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for 160 Health International and its competitors.
Is 160 Health International's Other Financing too high?
160 Health International's current Other Financing is HK$369.5 Mil. Overall, 160 Health International has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does 160 Health International's Other Financing compare to MCK and COR?
160 Health International's Other Financing of HK$369.5 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Distribution company?
A good Other Financing depends on the Medical Distribution industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for 160 Health International and its competitors. 160 Health International's current Other Financing is HK$369.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 160 Health International stock overvalued right now?
160 Health International (HKSE:02656) has a current Other Financing of HK$369.5 Mil. The current Other Financing is HK$369.5 Mil. 160 Health International's overall GF Score™ is 8/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For 160 Health International (HKSE:02656), the current Other Financing is HK$369.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

160 Health International Business Description

Address 4078 Dongbin Road, Nanshan Street, 9th, 11th - 12th Floor, Building 2, Yongxin Times Square, Nanshan District, Shenzhen, CHN, 518052
160 Health International Ltd is an experienced pharmaceutical and healthcare product wholesaler and a digital healthcare integrated service provider in China. The company offers a wide assortment of high-quality pharmaceutical and healthcare products under both wholesale and retail models, to address a spectrum of customer needs. In addition, through its online healthcare and wellness service platform, Healthcare 160 Platform. It also provide digital healthcare and wellness solutions, empowering each Platform Participants, including business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants, throughout the healthcare value chain and driving the digital transformation of China's healthcare and wellness industry.
8GF Score

Get the complete analysis for HKSE:02656

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$9.64
Price